The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
Open accessAbstract
Cannabis use is highly prevalent among people with schizophrenia, and coupled with impaired cognition, is thought to heighten the risk of illness onset. However, while heavy cannabis use has been associated with cognitive deficits in long-term users, studies among patients with schizophrenia have been contradictory. This article consists of 2 studies. In Study I, a meta-analysis of 10 studies comprising 572 patients with established schizophrenia (with and without comorbid cannabis use) was conducted. Patients with a history of cannabis use were found to have superior neuropsychological functioning. This finding was largely driven by studies that included patients with a lifetime history of cannabis use rather than current or recent use. In Study II, we examined the neuropsychological performance of 85 patients with first-episode psychosis (FEP) and 43 healthy nonusing controls. Relative to controls, FEP patients with a history of cannabis use (FEP + CANN; n = 59) displayed only selective neuropsychological impairments while those without a history (FEP - CANN; n = 26) displayed generalized deficits. When directly compared, FEP + CANN patients performed better on tests of visual memory, working memory, and executive functioning. Patients with early onset cannabis use had less neuropsychological impairment than patients with later onset use. Together, these findings suggest that patients with schizophrenia or FEP with a history of cannabis use have superior neuropsychological functioning compared with nonusing patients. This association between better cognitive performance and cannabis use in schizophrenia may be driven by a subgroup of "neurocognitively less impaired" patients, who only developed psychosis after a relatively early initiation into cannabis use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Specific impairments of planning
Shallice, T. (1982) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1982.0082 · Cited by 3,741
L’examen Clinique en Psychologie
Rubé, P. (1959) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1959.13.4.989 · Cited by 3,302
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., Essock, S., Fenton, W. S., Frese, F. J., Gold, J. M., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010042 · Cited by 2,342
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,050
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
Planning and spatial working memory following frontal lobe lesions in man
Owen, A. M., Downes, J. J., Sahakian, B. J., Polkey, C. E., & Robbins, T. W. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90137-d · Cited by 1,245
Causal association between cannabis and psychosis: examination of the evidence
Arseneault, L., Cannon, M., Witton, J., & Murray, R. M. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.2.110 · Cited by 913
Cognitive Functioning of Long-term Heavy Cannabis Users Seeking Treatment
Solowij, N. (2002) · JAMA · doi:10.1001/jama.287.9.1123 · Cited by 798
Self-citationComputerized assessment in neuropsychiatry using CANTAB: discussion paper.
Sahakian, B. J., & Owen, A. M. (1992) · Europe PMC (PubMed Central) · Cited by 794
Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & de Ceballos, M. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 785
Cannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders
Linszen, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 656
Haro, J. M., Kamath, S. A., Ochoa, S., Novick, D., Rele, K., Fargas, A., Rodríguez, M. J., Rele, R., Orta, J., Kharbeng, A., et al. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.107.s416.5.x · Cited by 656
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617
Dose-related neurocognitive effects of marijuana use
Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002) · Neurology · doi:10.1212/01.wnl.0000031422.66442.49 · Cited by 608
Prevalence of Substance Abuse in Schizophrenia: Demographic and Clinical Correlates
Mueser, K. T., Yarnold, P. R., Levinson, D. F., Singh, H., Bellack, A. S., Kee, K., Morisson, R. L., & Yadalam, K. G. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.1.31 · Cited by 587
Early-onset cannabis use and cognitive deficits: what is the nature of the association?
Pope, H. G., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., & Yurgelun-Todd, D. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00334-4 · Cited by 543
Owen, A. M., Sahakian, B. J., Semple, J., Polkey, C. E., & Robbins, T. W. (1995) · Neuropsychologia · doi:10.1016/0028-3932(94)00098-a · Cited by 525
Bax, L., Yu, L.-M., Ikeda, N., Tsuruta, H., & Moons, K. G. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-50 · Cited by 514 · cited 1×
“Meta-analyses were performed using MIX software.(31) Meta-regression analyses examined the effect of moderator variables on between-group differences.”
MethodRegional Brain Abnormalities Associated With Long-term Heavy Cannabis Use
Yücel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., Pantelis, C., & Lubman, D. I. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.6.694 · Cited by 497
Self-citationCannabis as a risk factor for psychosis: Systematic review
Semple, D. M., McIntosh, A. M., & Lawrie, S. M. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105049040 · Cited by 420
Medication adherence of individuals with a first episode of psychosis
Coldham, E. L., Addington, J., & Addington, D. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02437.x · Cited by 413
Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study
GRANT, I., GONZALEZ, R., CAREY, C. L., NATARAJAN, L., & WOLFSON, T. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703950016 · Cited by 411
Velakoulis, D., Pantelis, C., McGorry, P. D., Dudgeon, P., Brewer, W., Cook, M., Desmond, P., Bridle, N., Tierney, P., Murrie, V., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.2.133 · Cited by 354
Self-citationLambert, M., Conus, P., Lubman, D. I., Wade, D., Yuen, H., Moritz, S., Naber, D., McGorry, P. D., & Schimmelmann, B. G. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00554.x · Cited by 349
Self-citationRate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
Koskinen, J., Lohonen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp031 · Cited by 320
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Morgan, C. J. A., & Curran, H. V. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046649 · Cited by 300
Morrison, P. D., Zois, V., McKeown, D. A., Lee, T. D., Holt, D. W., Powell, J. F., Kapur, S., & Murray, R. M. (2009) · Psychological Medicine · doi:10.1017/s0033291709005522 · Cited by 298
Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity
Volkow, N. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp016 · Cited by 273
Cannabis Use and Age at Onset of Schizophrenia
Veen, N. D., Selten, J.-P., van der Tweel, I., Feller, W. G., Hoek, H. W., & Kahn, R. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.501 · Cited by 266
Reasons for increased substance use in psychosis
Gregg, L., Barrowclough, C., & Haddock, G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.09.004 · Cited by 249
Cannabis use and outcome of recent onset psychosis
Grech, A., Van Os, J., Jones, P. B., Lewis, S. W., & Murray, R. M. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.09.013 · Cited by 230
The relationship between non‐acute adolescent cannabis use and cognition
HARVEY, M. A., SELLMAN, J. D., PORTER, R. J., & FRAMPTON, C. M. (2007) · Drug and Alcohol Review · doi:10.1080/09595230701247772 · Cited by 222
Spatial working memory ability is a marker of risk-for-psychosis
WOOD, S. J., PANTELIS, C., PROFFITT, T., PHILLIPS, L. J., STUART, G. W., BUCHANAN, J.-A., MAHONY, K., BREWER, W., SMITH, D. J., & McGORRY, P. D. (2003) · Psychological Medicine · doi:10.1017/s0033291703008067 · Cited by 221
Self-citationCannabis, Vulnerability, and the Onset of Schizophrenia: An Epidemiological Perspective
Hambrecht, M., & Häfner, H. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00736.x · Cited by 205
Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia?
Solowij, N., & Michie, P. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0705 · Cited by 203
Self-citationCannabis use and the risk of later schizophrenia: a review
Smit, F., Bolier, L., & Cuijpers, P. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00683.x · Cited by 203
Sevy, S., Burdick, K. E., Visweswaraiah, H., Abdelmessih, S., Lukin, M., Yechiam, E., & Bechara, A. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.005 · Cited by 193
Reitan, R. (2004) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(03)00042-8 · Cited by 168
Neuropsychology of the Deficit Syndrome: New Data and Meta-analysis of Findings To Date
Cohen, A. S., Saperstein, A. M., Gold, J. M., Kirkpatrick, B., Carpenter, W. T., & Buchanan, R. W. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl066 · Cited by 163
Potvin, S., Joyal, C. C., Pelletier, J., & Stip, É. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.022 · Cited by 151
Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls
Jockers-Scherübl, M. C., Wolf, T., Radzei, N., Schlattmann, P., Rentzsch, J., de Castro, A. G.-C., & Kühl, K.-P. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.006 · Cited by 144
Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up
Stirling, J., Lewis, S. W., Hopkins, R., & White, C. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.10.006 · Cited by 133
Do cognitive impairments recover following cessation of cannabis use ?
Solowij, N. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00197-e · Cited by 133
Self-citationPrediction of the course and outcome of depression
Jablensky, A. V. (1987) · Psychological Medicine · doi:10.1017/s0033291700012915 · Cited by 123
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation
Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R., & Berry, E. M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.021 · Cited by 114
The role of cannabis in cognitive functioning of patients with schizophrenia
Schnell, T. G., Koethe, D., Daumann, J., & Gouzoulis‐Mayfrank, E. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1512-9 · Cited by 112
Comorbid substance-use in schizophrenia: Relation to positive and negative symptoms
Talamo, A., Centorrino, F., Tondo, L., Dimitri, A., Hennen, J. A., & Baldessarini, R. J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.04.004 · Cited by 111
Mathias, S., Lubman, D. I., & Hides, L. M. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0304 · Cited by 111
Self-citationCannabis use and cognition in schizophrenia
Løberg, E., & Hugdahl, K. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.053.2009 · Cited by 101
Cannabis, Cannabinoids and Schizophrenia: Integration of the Evidence
Cohen, M. A., Solowij, N., & Carr, V. J. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670801961156 · Cited by 101
Self-citationJoyal, C. C., Hallé, P., Lapierre, D., & Hodgins, S. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00387-0 · Cited by 101
Verrico, C. D., Jentsch, J. D., & Roth, R. H. (2003) · Synapse · doi:10.1002/syn.10215 · Cited by 98
Velakoulis, D., Wood, S. J., Smith, D. J., Soulsby, B., Brewer, W. J., Leeton, L., Desmond, P. M., Suckling, J., Bullmore, E. T., McGuire, P. K., et al. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00307-3 · Cited by 97
Self-citationResidual neuropsychologic effects of cannabis
Pope, H. G., Gruber, A. J., & Yurgelun-Todd, D. A. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-001-0045-7 · Cited by 92
Dubertret, C., Bidard, I., Adès, J., & Gorwood, P. A. P. M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.006 · Cited by 85
DeLisi, L. E. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f51266 · Cited by 85
CANTAB explicit memory is less impaired in addicted schizophrenia patients.
Potvin, S., Briand, C., Prouteau, A., Bouchard, R., Lipp, O., Lalonde, P., Nicole, L., Lesage, A., & Stip, E. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2005.04.002 · Cited by 81
Coulston, C. M., Perdices, M., & Tennant, C. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.08.006 · Cited by 74
Mata, I. F., Rodríguez-Sánchez, J. M., Pelayo‐Terán, J. M., Pérez‐Iglesias, R., González‐Blanch, C., Ramírez-Bonilla, M. L., Martínez‐García, O., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2007) · Psychological Medicine · doi:10.1017/s0033291707002218 · Cited by 73
Nutrition, growth, and development
Tizard, J. (1976) · Psychological Medicine · doi:10.1017/s003329170000742x · Cited by 70
The deficit syndrome in the Suffolk County Mental Health Project
Kirkpatrick, B. W., Ram, R., & Bromet, E. J. (1996) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00057-6 · Cited by 68
Ringen, P. A., Vaskinn, A., Sundet, K. S., Engh, J. A., Jónsdóttir, H., Simonsen, C., Friis, S., Opjordsmoen, S., Melle, I. S., & Andreassen, O. A. (2009) · Psychological Medicine · doi:10.1017/s0033291709991620 · Cited by 68
de la Serna, E., Mayoral, M., Baeza, I., Arango, C., Andrés, P., Bombín, I., González, C., Rapado‐Castro, M., Robles, O., Rodríguez-Sánchez, J. M., et al. (2010) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3181cc0d41 · Cited by 63
Ringen, P. A., Melle, I. S., Birkenaes, A. B., Engh, J. A., Færden, A., Vaskinn, A., Friis, S., Opjordsmoen, S., & Andreassen, O. A. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01244.x · Cited by 61
Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia
SCHWARCZ, G., Karajgi, B. M., & McCarthy, R. H. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a6bc3b · Cited by 60
Scholes‐Balog, K. E., & Martin-Iverson, M. T. (2009) · Psychological Medicine · doi:10.1017/s0033291709992078 · Cited by 55
Coulston, C. M., Perdices, M., & Tennant, C. C. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701634952 · Cited by 50
Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use
Ruíz-Veguilla, M., Gurpegui, M., Barrigón, M. L., Ferrín, M., Marín, E., Rubio, J. L., Gutiérrez, B., Pintor, A. V., & Cervilla, J. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.001 · Cited by 46
Kumra, S., Thaden, E. P., DeThomas, C., & Kranzler, H. N. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.006 · Cited by 41
Liraud, F., & Verdoux, H. (2002) · PubMed · Cited by 33
Royal Park Multidiagnostic Instrument for Psychosis
McGorry, P. D., SINGH, B. S., Copolov, D., et al. (1990) · PsycTESTS Dataset · doi:10.1037/t12690-000 · Cited by 31
Self-citationBacon, A., Granholm, E. L., & Withers, N. (1998) · PubMed · Cited by 12
Familial Psychopathology in the First Episode Psychosis Outcome Study
Morley, K. I., Cotton, S., Conus, P., Lambert, M., SCHIMMELMANN, B. G., McGorry, P. D., & Foley, D. L. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802119754 · Cited by 10
Self-citation
Cited by
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
McCutcheon, R. A., Keefe, R. S. E., & McGuire, P. K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01949-9 · Cited by 741
Keep off the grass? Cannabis, cognition and addiction
Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.28 · Cited by 389
Prefrontal Cortical Dendritic Spine Pathology in Schizophrenia and Bipolar Disorder
Konopaske, G. T., Lange, N., Coyle, J. T., & Benes, F. M. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1582 · Cited by 379
Cannabis and adolescent brain development.
Lubman, D. I., Cheetham, A., & Yücel, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.009 · Cited by 360
Schoeler, T., Monk, A., Sami, M. B., Klamerus, E., Foglia, E., Brown, R., Camuri, G., Altamura, A. C., Murray, R., & Bhattacharyya, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00363-6 · Cited by 322
Metadata
- Authors
- Yucel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M., Conus, P., Takagi, M. J., Fornito, A., Wood, S. J., McGorry, P. D., & Pantelis, C.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-25
- Volume
- 38
- Issue
- 2
- Pages
- 316-330
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2101076435
- Cited by
- 255
- References
- 77
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.